Alzheon
Phase 3Alzheon is committed to developing breakthrough medicines for patients suffering from Alzheimer's disease and other neurological disorders.
Founded
2013
Focus
Small Molecules
About
Alzheon is committed to developing breakthrough medicines for patients suffering from Alzheimer's disease and other neurological disorders.
Funding History
13Total raised: $355.2M
Grant$2.3MNIAJul 10, 2024
Series D$100MUndisclosedJun 12, 2024
Grant$425KNIAJul 14, 2023
Grant$6.5MNIAJun 14, 2023
Company Info
TypePrivate
Founded2013
LocationFramingham, United States
StagePhase 3
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile